Literature DB >> 7381651

The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979).

G S Perry, B D Spector, L M Schuman, J S Mandel, V E Anderson, R B McHugh, M R Hanson, S M Fahlstrom, W Krivit, J H Kersey.   

Abstract

Information was collected on 301 cases of the Wiskott-Aldrich syndrome in the United States and Canada Examination of available medical records, death certificates and published case reports on these patients showed that they came from a wide geographic area and many diverse ethnic and racial groups. No significant difference was found in the incidence of cases born between 1947 and 1976; the overall rate was 4.0 per million live male births in the United States. Median survival has increased with time from eight months for patients born before 1935 to 6.5 years for those born after 1964. Seventy-six of the 301 patients (25%) were still alive at last follow-up and ranged in age from 1 to 36 years with a median of 10 years. Causes of death were primarily limited to infections or bleeding, but malignancy represented a significant problem. Twelve percent of the group (36 of 301) developed malignancy, the predominant types being lymphorecticular tumors (23 of 36) and leukemia (7 of 36). The overall relative risk for malignancy was found to be greater than 100 times that of the general population and was found to increase with increasing age.

Entities:  

Mesh:

Year:  1980        PMID: 7381651     DOI: 10.1016/s0022-3476(80)80133-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  36 in total

1.  Management of Wiskott-Aldrich syndrome.

Authors:  A Srivastava; H A Swaid; M Kabra; I C Verma
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

2.  Development of diffuse large cell lymphoma from follicular lymphoma with multiple immunoglobulin heavy chain gene rearrangement occurring in a patient with Wiskott-Aldrich syndrome.

Authors:  Keiki Kawakami; Motoko Yamaguchi; Yasuyuki Watanabe; Tetsuya Murata
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  Primary lymphoma of the central nervous system.

Authors:  P Fernandes; A D Chowdhury; K G Badami; N R Dutta; G K Rath
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

Review 4.  Wiskott-Aldrich syndrome: a multidisciplinary disease.

Authors:  G R Standen
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

Review 5.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

6.  Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.

Authors:  Naynesh R Kamani; Shimareet Kumar; Anna Hassebroek; Mary Eapen; Jennifer LeRademacher; James Casper; Morton Cowan; José Sánchez de Toledo; Alina Ferster; Paul Szabolcs; John R Wingard; Edwin Horwitz; Alexandra H Filipovich
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-20       Impact factor: 5.742

7.  Linkage studies of the Wiskott-Aldrich syndrome: polymorphisms at TIMP and the X chromosome centromere are informative markers for genetic prediction.

Authors:  W L Greer; M M Mahtani; P C Kwong; L A Rubin; M Peacocke; H F Willard; K A Siminovitch
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

8.  Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.

Authors:  Hikmet G Tanyildiz; Handan Dincaslan; Gulsan Yavuz; Emel Unal; Aydan Ikinciogulları; Figen Dogu; Nurdan Tacyildiz
Journal:  J Clin Immunol       Date:  2016-08-04       Impact factor: 8.317

9.  N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.

Authors:  Tracey A Martin; Gordon Pereira; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

10.  Incidence of cancer in 98 patients with common varied immunodeficiency.

Authors:  C Cunningham-Rundles; F P Siegal; S Cunningham-Rundles; P Lieberman
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.